The effect of obesity on metabolic parameters: a cross sectional study in adult women.
Abdominal Fat
Anthropometry
Blood Chemical Analysis
Obesity
Women's Health
Journal
African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
medline:
25
4
2023
pubmed:
24
4
2023
entrez:
24
04
2023
Statut:
ppublish
Résumé
In this study conducted in adult healthy women, it was aimed to determine the relationship between anthropometric measurements such as Body Mass Index (BMI), waist circumference, waist/height ratio and blood parameters, which are used to define obesity. A total of 90 women, with a mean age of 38.4±8.8 years, 34 pre-obese between BMI: 25.0-29.9 kg/m2 and 56 obese BMI: ≥30.0 kg/m2, participated in the study. According to plasma atherogenic index (PAI), women with high cardiovascular risk had lower high-density lipoprotein (HDL) values, while low-density lipoprotein (LDL), triglyceride (TG), aspartate transaminase (AST) values were found to be higher (p<0.05). It was observed that obese women according to BMI had higher fasting glucose, TG, alanine transaminase (ALT), AST and urea values, and lower HDL and mean erythrocyte volume (MCV) values compared to pre-obese women (p<0.05). A moderately positive relationship was found between body fat percentage, waist circumference and waist/height ratio and fasting glucose and ALT levels of women, and a moderate negative relationship was found between vitamin D levels (p<0.05). It is understood that the increase in body fat tissue, especially in the abdominal region, in adult healthy women has negative effects on blood parameters and the risk of developing chronic diseases will decrease by preventing this situation.
Sections du résumé
Background
UNASSIGNED
In this study conducted in adult healthy women, it was aimed to determine the relationship between anthropometric measurements such as Body Mass Index (BMI), waist circumference, waist/height ratio and blood parameters, which are used to define obesity.
Methods
UNASSIGNED
A total of 90 women, with a mean age of 38.4±8.8 years, 34 pre-obese between BMI: 25.0-29.9 kg/m2 and 56 obese BMI: ≥30.0 kg/m2, participated in the study.
Results
UNASSIGNED
According to plasma atherogenic index (PAI), women with high cardiovascular risk had lower high-density lipoprotein (HDL) values, while low-density lipoprotein (LDL), triglyceride (TG), aspartate transaminase (AST) values were found to be higher (p<0.05). It was observed that obese women according to BMI had higher fasting glucose, TG, alanine transaminase (ALT), AST and urea values, and lower HDL and mean erythrocyte volume (MCV) values compared to pre-obese women (p<0.05). A moderately positive relationship was found between body fat percentage, waist circumference and waist/height ratio and fasting glucose and ALT levels of women, and a moderate negative relationship was found between vitamin D levels (p<0.05).
Conclusions
UNASSIGNED
It is understood that the increase in body fat tissue, especially in the abdominal region, in adult healthy women has negative effects on blood parameters and the risk of developing chronic diseases will decrease by preventing this situation.
Identifiants
pubmed: 37092065
doi: 10.4314/ahs.v22i4.29
pii: jAFHS.v22.i4.pg241
pmc: PMC10117476
doi:
Substances chimiques
Triglycerides
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
241-251Informations de copyright
© 2022 Karadogan SR et al.
Déclaration de conflit d'intérêts
This study has no funding and the authors declare no conflict of interest or potential conflict of interest.
Références
Arch Med Res. 2019 Jul;50(5):285-294
pubmed: 31593853
Curr Oncol Rep. 2019 Jul 1;21(8):72
pubmed: 31263961
Endocrine. 2018 Feb;59(2):330-337
pubmed: 29170904
J Diet Suppl. 2018 Sep 3;15(5):596-605
pubmed: 28981381
Int J Obes (Lond). 2005 Mar;29(3):310-6
pubmed: 15672112
BMC Pediatr. 2010 Oct 11;10:73
pubmed: 20937123
Lancet. 2019 Feb 23;393(10173):791-846
pubmed: 30700377
Trends Endocrinol Metab. 2021 May;32(5):264-294
pubmed: 33707095